Sahebkar et al. · 2013 · Ingredient Evidence
Curcuminoids modulate pro-oxidant–antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals
- Evidence Type
- Randomized, double-blind, placebo-controlled crossover human trial.
- Studied Material / Formulation
- Curcuminoid supplement; detailed formulation not established from the reviewed abstract.
- Population
- 30 adults with obesity.
- Dose
- 1 g curcuminoids/day.
- Duration
- Two 30-day periods; 2-week washout.
- Main Findings
- Pro-oxidant–antioxidant balance decreased; antibodies to Hsp27 and oxidized LDL did not change significantly.
- Limitations
- Small, short biomarker trial; higher dose and different population. Full formulation and funding require full-text review.
- Product Relevance
- Antioxidant research context; not evidence for disease treatment or this finished product.
- DR.MORGAN finished product studied
- NO
This study was not conducted on the finished DR.MORGAN product.
Source review: PubMed abstract and metadata; full methods not reviewed. DOI 10.1002/ptr.4952. PMID 23494802.